Brewing controversy, the Central Bureau of Investigation (CBI) alleged senior Central Drugs Standards Control Organisation (CDSCO) officials colluded with Biocon Biologics to waive the phase-3 clinical trial of the diabetes drug ‘Insulin Aspart injection’. However, Biocon has refuted the allegation reiterating that it strongly condemns all acts of bribery and corruption.

The FIR filed by CBI in the alleged bribery case involving pharma companies and drug control officials claims that Biocon Biologics Limited) official S Eswara Reddy, who had been dealing with processing of files related to applications for approval of drugs and vaccines by various pharma companies, had been referred three files of Biocon Biologics Limited, Bengaluru, including one related to waiver of phase III clinical trials of “Insulin Aspart” injection.

For more details, check out the full story on the link below:       

Product Approvals Legitimate: Biocon After CBI Detains CDSCO Officials In Kickback Case

Leave a Reply

Your email address will not be published. Required fields are marked *